Amicus Therapeutics Inc
NASDAQ:FOLD
Amicus Therapeutics Inc
Depreciation & Amortization
Amicus Therapeutics Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Amicus Therapeutics Inc
NASDAQ:FOLD
|
Depreciation & Amortization
-$8.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-18%
|
|
Abbvie Inc
NYSE:ABBV
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Depreciation & Amortization
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Amicus Therapeutics Inc's Depreciation & Amortization?
Depreciation & Amortization
-8.7m
USD
Based on the financial report for Mar 31, 2024, Amicus Therapeutics Inc's Depreciation & Amortization amounts to -8.7m USD.
What is Amicus Therapeutics Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-18%
Over the last year, the Depreciation & Amortization growth was -68%. The average annual Depreciation & Amortization growth rates for Amicus Therapeutics Inc have been -1% over the past three years , -15% over the past five years , and -18% over the past ten years .